Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Single institution experience of split course radiotherapy in patients with desmoid tumors.

Luo J, Jin K, Qian S, Ma X, Pan Z, Yao W, Zhang Z, Guo X, Yu X.

Onco Targets Ther. 2019 Mar 7;12:1741-1748. doi: 10.2147/OTT.S189449. eCollection 2019.

2.

Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.

Youssef E, Fontanesi J, Mott M, Kraut M, Lucas D, Mekhael H, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):514-9.

PMID:
12243830
3.

The significance of radiotherapy treatment duration in intracranial ependymoma.

Paulino AC, Wen BC.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):585-9.

PMID:
10837939
4.

Long-term outcomes for desmoid tumors treated with radiation therapy.

Guadagnolo BA, Zagars GK, Ballo MT.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):441-7. Epub 2008 Feb 20.

PMID:
18068311
5.

Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients.

Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1167-1174. doi: 10.1016/j.ijrobp.2018.12.012. Epub 2018 Dec 12.

PMID:
30552963
6.

Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?

Jen YM, Lin YS, Su WF, Hsu WL, Hwang JM, Chao HL, Liu DW, Chen CM, Lin HY, Wu CJ, Chang LP, Shueng PW.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):14-22.

PMID:
12182970
7.

The Role of Radiotherapy in the Treatment of Primary or Recurrent Desmoid Tumors and Long-Term Results.

Ergen ŞA, Tiken EE, Öksüz DÇ, Dinçbaş FÖ, Dervişoğlu S, Mandel NM, Hız M, Koca S.

Balkan Med J. 2016 May;33(3):316-21. doi: 10.5152/balkanmedj.2016.140560. Epub 2016 May 1.

8.

Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1. A Radiation Therapy Oncology Group Study.

Marcial VA, Amato DA, Brady LW, Johnson RJ, Goodman R, Martz KL, Hanley JA.

Am J Clin Oncol. 1985 Jun;8(3):185-99.

PMID:
4050737
9.

Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.

Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M; Dokuz Eylül Lung Cancer Study Group.

J BUON. 2006 Jan-Mar;11(1):31-7.

PMID:
17318949
10.

Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.

Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.

Radiat Oncol Investig. 1999;7(5):297-308.

PMID:
10580899
11.
12.

The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.

Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):659-65.

PMID:
9336146
13.

Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.

Ohnleiter T, Antoni D, Lefebvre F, Truntzer P, Schultz P, Burgy M, Borel C, Noël G.

Chin Clin Oncol. 2018 Dec;7(6):60. doi: 10.21037/cco.2018.06.07. Epub 2018 Jun 27.

14.

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A.

Cochrane Database Syst Rev. 2017 Sep 13;9:CD008814. doi: 10.1002/14651858.CD008814.pub2. Review.

PMID:
28901021
15.

Radiotherapy in desmoid tumors : Treatment response, local control, and analysis of local failures.

Santti K, Beule A, Tuomikoski L, Rönty M, Jääskeläinen AS, Saarilahti K, Ihalainen H, Tarkkanen M, Blomqvist C.

Strahlenther Onkol. 2017 Apr;193(4):269-275. doi: 10.1007/s00066-016-1091-8. Epub 2017 Jan 2.

PMID:
28044201
16.

Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.

Gandhi AK, Roy S, Biswas A, Raza MW, Saxena T, Bhasker S, Sharma A, Thakar A, Mohanti BK.

Auris Nasus Larynx. 2016 Feb;43(1):45-9. doi: 10.1016/j.anl.2015.06.005. Epub 2015 Jul 9.

PMID:
26165629
17.

Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.

Askoxylakis V, Hegenbarth P, Timke C, Saleh-Ebrahimi L, Debus J, Röder F, Huber PE.

Radiat Oncol. 2016 Feb 4;11:17. doi: 10.1186/s13014-016-0595-9.

18.

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Fayette J, Molin Y, Lavergne E, Montbarbon X, Racadot S, Poupart M, Ramade A, Zrounba P, Ceruse P, Pommier P.

Drug Des Devel Ther. 2015 Nov 26;9:6203-10. doi: 10.2147/DDDT.S81488. eCollection 2015.

19.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
20.

Late effects in children treated with radiation therapy for Wilms' tumor.

Paulino AC, Wen BC, Brown CK, Tannous R, Mayr NA, Zhen WK, Weidner GJ, Hussey DH.

Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1239-46.

PMID:
10725637

Supplemental Content

Support Center